[1]
Deva kumar.K et al. 2025. INCIDENCE AND SAFETY PROFILE OF POLYVALENT ANTIVENOM IN HEMOTOXIC AND NEUROTOXIC SNAKEBITE VICTIMS: A TERTIARY CARE EXPERIENCE. Journal of Population Therapeutics and Clinical Pharmacology. 32, 7 (Aug. 2025), 290–303. DOI:https://doi.org/10.53555/jk8d0w46.